Log in or Sign up for Free to view tailored content for your specialty!
Transplantation News
Exclusive preview: ANNA fall meeting to center on future of nursing, larger realm of health care
On Oct. 12, nurses who specialize in caring for patients with varying degrees of kidney disease will gather in San Diego for the American Nephrology Nurses Association’s Nephrology Nursing Practice, Management & Leadership Conference. Mary Schira, PhD, RN, ACNP-BC, ANNA conferences committee chair and an associate professor in the College of Nursing and Health Innovation at the University of Texas, told Healio/Nephrology that the conference is equally open to nurse managers, staff nurses and advanced practice nurses.
New Kidney Allocation System has not ended socioeconomic disparities in preemptive transplant
Despite the implementation of the Kidney Allocation System in 2014, black and Hispanic patients — as well as those receiving Medicare instead of holding private insurance —continue to have lower odds of preemptive kidney transplantation, according to a recently published study.
Log in or Sign up for Free to view tailored content for your specialty!
Validated prediction tool estimates graft failure after kidney transplant
A risk prediction score — made up of eight prognostic factors — demonstrated accuracy in determining allograft failure after kidney transplantation.
Q&A: Guideline updates for HCV infection in patients with chronic kidney disease
The introduction and success of direct-acting antivirals drove the Kidney Disease: Improving Global Outcomes work group to make major updates to its clinical practice guidelines regarding hepatitis C virus infection in chronic kidney disease, or CKD.
Risk factors for graft loss 1-year after kidney transplant identified
Researchers have identified six factors associated with graft loss 1 year after kidney transplantation.
Kidney donors at higher risk for hypertension which may halt post-donation eGFR rise
Researchers of a recently published study found kidney donors had a greater risk for hypertension than non-donors. In addition, those who developed hypertension experienced a plateau in the usual post-donation eGFR increase.
Maribavir shows promise against CMV in transplant recipients
Twice-daily maribavir demonstrated similar efficacy as valganciclovir in clearing cytomegalovirus viremia in hematopoietic-cell or solid-organ transplant recipients, according to results from a phase 2 trial published today in The New England Journal of Medicine.
HCV-viremic kidneys provide similar efficacy in recipients as uninfected organs
By 2019, hepatitis C-seronegative patients who underwent kidney transplantation mostly received HCV-viremic donor organs, which demonstrated the same level of function as uninfected kidneys over the course of 1-year follow-up.
Findings support efficacy of kidneys from donors with hepatitis C virus for transplant
Researchers of a recently published study found kidneys from donors infected with the hepatitis C virus functioned similarly to kidneys from donors without the virus 1 year after transplant. In addition, these kidneys are gaining greater acceptance from transplant centers and are increasingly transplanted into recipients without preexisting hepatitis C virus which, according to Peter P. Reese, MD, MSCE, of the University of Pennsylvania, is a “huge change from past practice.”
Dialysis at for-profit facilities may mean reduced access to kidney transplant
Compared with nonprofit facilities, patients who received dialysis at for-profit facilities had a lower likelihood of accessing kidney transplantation, according to a recently published study.